PATENT CLAIM ANALYSIS

Application Number: 15750479
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2019-01
Patent Classification: ["514", "050000"]

Abstract:
The present invention relates to salts of anthelmintic compounds with a benzimidazolic structure, such as albendazole (ABZ), fenbendazole (FBZ), triclabendazole (TRBZ), or sulphoxides thereof, flubendazole (FLZ), mebendazole (MBZ), oxibendazole (OBZ), thiabendazole (TBZ), cambendazole (CBZ), parbendazole (PBZ), nocodazole (NCZ), the use thereof and a process for preparation thereof.

Claim (Index 10):
Salt as defined in  claim 9 , wherein said tumour is selected in the group consisting of ovarian carcinoma, adrenocortical carcinoma, lung carcinoma, pancreatic tumours, breast tumours, colorectal cancer, kidney tumours, melanoma, glioblastoma multiforme, osteosarcoma, leukaemia and lymphomas.

Metadata:
- Claim Count in Document: 52.0
- Percentile: 88.0
- Lexical Diversity: 1.66667
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15111711', '14440140', '12801853', '10485530', '14085632']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.777410187658505
- 35 USC 102 Novelty (BERT): 0.4908415165014052
- Combined Prediction Score: 0.7487533205427951
- Mean Citation Score: 170.215304
- Max Citation Score: 183.41043
- Similarity Product: 120.39195546721456

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test